Commentary on the MIND-USA Trial
icTV interview with Carl Waldmann
In this video, Carl Waldmann discusses the strengths and challenges related to the MIND-USA: Phase III RCT, which compared antipsychotics with placebo for delirium and other ICU outcomes. The results of this clinical trial were presented at the Presidents’ Ground Breaking Research Release session LIVES 2018 in Paris and have been recently published in NEJM (click here).
Don’t miss the Clinical Trials in ICU session at LIVES 2018 on Tuesday…
Find more info and links to watch live online here.